Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Specialty and rare diseases often encompass patient populations that are not clearly defined, including individuals who remain undiagnosed or face misdiagnoses, along with healthcare providers who may lack knowledge about these conditions and their various manifestations, resulting in treatment pathways that are poorly understood. IPM.ai operates as an Insights-as-a-Service (IaaS) firm, dedicated to empowering leading life sciences organizations to gain deeper insights into patient care and enhance the quality of life for those affected through the development, clinical research, and commercialization of therapeutic solutions. By predicting market size, analyzing the competitive landscape, and estimating potential return on investment, companies can optimize their commercialization strategies. Additionally, the platform identifies undiagnosed and misdiagnosed individuals who could benefit from early disease interception and therapeutic measures. It employs statistical models to gauge the prevalence of specific diseases within certain patient populations at any given moment. Furthermore, IPM.ai helps pinpoint physicians who are adept at diagnosing and treating these ideal patients, while also influencing other healthcare providers to enhance overall patient outcomes. This comprehensive approach ultimately aims to bridge the gap in understanding and addressing the needs of those with rare diseases.
Description
The SMAF tools have been consolidated into a single, shareable information system, enabling automated calculations of SMAF profiles. This system offers reports that aid in analyzing results and creating assistance plans, making it straightforward for healthcare professionals to use. Additionally, it enhances networking and service organization without requiring any software installation. The iSMAF, marking the fifth significant version of our software, operates as web-based software that digitizes established clinical tools and processes linked to the SMAF tool. Specifically designed for Quebec, the iSMAF edition features the PRISMA-7, the SMAF evaluation grid, the social-SMAF, a generator for Iso-SMAF profiles, and a care table. Furthermore, it provides various functions that allow clinicians and managers to produce reports on specific subjects or groups, facilitating a comprehensive understanding of the establishment, the progression of profiles over time, or comparisons between different groups based on their profiles. This integration represents a significant advancement in streamlining the management of health assessments and planning.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
IPM.ai
Country
United States
Website
www.ipm.ai/platform
Vendor Details
Company Name
CESS
Founded
2013
Country
United States
Website
www.demarchesmaf.com/en/tools/web_software/